Atara Biotherapeutics, Inc. (LON:0HIY)
London
· Delayed Price · Currency is GBP · Price in USD 6.52
-0.76 (-10.44%)
At close: May 13, 2025
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of 33.57 million as of May 16, 2025. Its market cap has decreased by -51.00% in one year.
Market Cap
33.57M
Enterprise Value
43.26M
Revenue
154.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.52
Market Cap Chart
Since October 17, 2014, Atara Biotherapeutics's market cap has decreased from 144.86M to 33.57M, a decrease of -76.82%. That is a compound annual growth rate of -12.91%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 155.40B |
| GSK plc | 55.23B |
| Haleon | 35.54B |
| Smith & Nephew | 9.24B |
| ConvaTec Group | 5.43B |
| Hikma Pharmaceuticals | 4.59B |
| HUTCHMED (China) | 1.74B |
| Genus | 1.38B |